Apotex Corp. is voluntarily recalling 22,027 bottles of Timolol Maleate Ophthalmic Solution, USP 0.5% (2.5 mL size). The recall was issued because the medication failed stability tests due to liquid weight loss from the container, which can result in the medicine being stronger or weaker than intended. This prescription drug is typically used to lower pressure in the eyes for patients with conditions like glaucoma.
The drug may have lost its required potency over time because of excessive evaporation from the bottle. If the medication is not at the correct strength, it may not effectively treat high eye pressure, potentially leading to a worsening of the patient's vision or eye health.
You have 2 options:
Recall Number: D-0093-2023
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.